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Introduction. Oligometastatic disease it is a common situation in our daily clinical practice. Non-invasive treatments as a SBRT
can be a feasible therapeutic choice. We present our preliminary experience using single fraction of 34Gy in solitary lesions
localized in Lung.
Objectives. Main aim of this report is to show that single fraction of 34Gy in lung is a feasible treatment for pulmonary lesions in
oligometastatic patients with low rates of acute toxicity.
Material and methods. Seven patients with 7 pulmonary lesions were treated with a single dose of 34Gy. Inclusion criteria were:
lesion size smaller than 2 cm, distance from the chest wall and main bronchus tree higher than 2 cm, primary tumor under
control in PET scan.Mean age 61.57 y (r39–82), Gender distribution 3women and 4men, Histology: 4 cases (57.14%weremetastatic
lesions from colon), 1 metastatic from Adenoid Cystic, 1 Adenocarcinoma from Lung and 1 NSCLC. All patients underwent 4DCT
for contouring. Inmobilization was done by thermoplastic mask (Lorca Marin). Dosimetric characteristics: Mean volume of GTV
1.46 cm3 (r0.6–4.1), mean volume of PTV 11.29 cm3 (r7.1–22.2), D Max oesophagus 5.06 (r2.6–8.4), D max Heart 4.05 (r6.86–17.0), D
max trachea 5.12Gy (r0.3–11.1), Dmax skin 10.98 (r7.0–14.4). Patientswere treated using True Beammachine. In 6 cases treatments
were delivered without ﬂattering ﬁlter.
Results. After 3 months of follow up (r6–2.19) no toxicity higher than grade 2 was detected. Local control and survival rates are
100%, 100% respectively. To sum up, even this is a preliminary study, seems that long-term results can show us a new perspective
in these oligometastatic patients.
http://dx.doi.org/10.1016/j.rpor.2013.03.319
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Purpose. To report experience treating lung cancer lesions by SBRT in Hospital Ramón y Cajal, Madrid.
Patients and methods. We report data of 19 lung cancer lesions (18 stages I and II a, non small cell lung cancer and 1 colon cancer
metastases), in patients treated between 2011 and 2012 by SBRT. All the lesions were less than 5 cm. PET-CT was carried out to
all patients for staging. The immobilization system used was dampening. SBRT was performed with three different schedules,
depending on the size and location of the tumor: 3 fractions of 20Gy, 5 fractions of 12Gy and 8 fractions of 7.5Gy. Daily control
with cone-beam CT was used. Initially, two-monthly follow-up was carried out with CT scans and PET/CT, alternatively.
Results. Mean age was 74.6 years, 18 men (94.7%) and 1 woman (5.3%). Tumor location: central in 4 patients (21.1%), medium in
10 (52.6%) and peripheral in 5 (26.3%). The tumor size range was between 12 and 48 mm: eight patients T1a (42.1%), 5 patients
T1b (26.3%), 5 patients T2a (26.3%) and 1 patient with a metastasis of 2 cm. Four patients (21.1%) were treated with 3 fractions of
20Gy; nine patients (47.4%) with 5 fractions of 12Gy and six (31.6%) received 8 fractions of 7.5Gy. Acute side effects were mild: Rib
fracture in 1 patient, and grade 2 local dermatitis, in 2 patients. The median follow-up was 11 months. Local control were 88.4%.
Distant metastases were seen in 3 patients (15.7%), 2 of them with local control. Overall survival rates were 94.7%. Disease-free
survival rates were 73.6%.
Conclusion. SBRT can be performed in an easy and comfortable way. Using a moderate dose schedule, SBRT is a well-tolerated
treatment and it leads to a favorable tumor control.
http://dx.doi.org/10.1016/j.rpor.2013.03.320
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Introduction. Stereotactic body radiation therapy (SBRT) requires to reach an exquisite immobilization and image control intra-
fraction, to deliver a conformal highly dose with high accuracy.
Objective(s). Describe the implementation of SBRT technique and to provide our preliminary clinical results using Helical
Tomotherapy (HT) for lung lesions.
Materials/methods. From August 2011 to January 2013, ﬁve patients with 8 non-central lung lesions (early-stage lung cancer n=3,
metastatic lesions n=5, all < 5 cm), medically inoperable, were treated with HT-SBRT. The sum of gross tumor volume (GTV)
